Profile
CUE VRTX REGN VRNA ARGX ALNY
Company Name Cue Biopharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $24.92M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.04K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Usman Azam Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
CUE VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
CUE VRTX REGN VRNA ARGX ALNY
Last Close $0.574 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.75 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.56 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -67.2 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 2.5 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
CUE VRTX REGN VRNA ARGX ALNY
1 Month Return -27.91 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -29.9 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -20.82 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -58.41 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -47.34 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -46.85 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CUE VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -165.58 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
CUE VRTX REGN VRNA ARGX ALNY
Asset Growth -47.68 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 128.48 % 1.16 % - 26.81 %
Revenue Growth 69.16 % 0.99 % - 22.97 %
Revenue 3 Year -65.48 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year 5.08 % 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 19.42 % 9.09 % -131.37 % 24.59 %
Net Income Growth 19.83 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 48.84 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 56.63 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -175.28 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 20.42 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 9.09 % - -143.33 % -107.98 %
Operating 3 Year CFG 48.05 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 53.84 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -186.09 % -100 % 40.15 % 97.08 %
EPS Growth 35.14 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 35.14 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -61.67 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -85.16 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -87.46 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -67.08 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -39.6 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 8.92 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
CUE VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 98.89 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -119.08 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -271.67 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -236.42 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 98.88 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -536.77 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -480.14 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 3.11 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.03 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 144.63 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 22.44 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.29 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.3 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 18.51 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -417.45 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.6 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -480.14 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.84 36.72 20 -995.27 128.45 195.85
Price To Operating Cash Flows Ratio TTM -1.08 32.86 16.23 -126.33 145.01 162.25
Price Cash Flow Ratio TTM -1.08 32.86 16.23 -126.33 145.01 162.25
Income Statement (TTM)
CUE VRTX REGN VRNA ARGX ALNY
Revenue $0.01B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0.01B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.04B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.04B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -0.72 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
CUE VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.02B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $16.08B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.03B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
CUE VRTX REGN VRNA ARGX ALNY
Net Income $-0.04B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.04B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to CUE
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0001 265.02
VTI Vanguard Total Stock Market Index Fund 0.00002 340.96
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00018 151.14
IWO iShares Russell 2000 Growth ETF 0.0002 339.48
VXF Vanguard Extended Market Index Fund 0.00034 217.96
HDG ProShares Hedge Replication ETF 0.000337966 52.68
UWM ProShares Ultra Russell2000 0.000674463 53.95
VTHR Vanguard Russell 3000 Index Fund 0 305.54
IWC iShares Micro-Cap ETF 0.00958 168.85
URTY ProShares UltraPro Russell2000 0.000320317 64.84
VFLQ Vanguard U.S. Liquidity Factor ETF 0.03 99.7611
VTWG Vanguard Russell 2000 Growth Index Fund 0 248.074
VTWO Vanguard Russell 2000 Index Fund 0 107.1
VUN.TO Vanguard U.S. Total Market Index ETF 0.00002 126.63
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00002 118.21
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 114.86
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.84
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00003 52.46
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00003 52.45
VBINX Vanguard Balanced Index Fund Investor Shares 0.00003 52.45
VALT ETFMG Sit Ultra Short ETF 0.23 48.52
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.01 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0 15.68
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.01
STSB iShares Factors US Small Blend Style ETF 0.08 21.66
GERM ETFMG Treatments, Testing and Advancements ETF 0.07 19.1577
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.34
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0 31.94
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.22
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.82
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.34 1.75
DFUS Dimensional U.S. Equity ETF 0.00000122 75.35
DFAS Dimensional U.S. Small Cap ETF 0.00010926 76.26
DFAC Dimensional U.S. Core Equity 2 ETF 0.00003557 41.29
VTSAX Vanguard Total Stock Market Index Fund 0.00002 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00034 165.43
VITSX Vanguard Total Stock Market Index Fund 0.00002 166.06
DFSU Dimensional US Sustainability Core 1 ETF 0.00000091 44.295
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000119166 16.66
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00034 165.44
VEXPX Vanguard Explorer Fd 0 120.94
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.0022685 42.86
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 65.27
VTS.AX Vanguard US Total Market Shares Index ETF 0.00002 479.23
DCOR Dimensional ETF Trust 0.00001195 76.48
VEMPX Vanguard Extended Market Index InstlPlus 0.00034 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 311.51
RSSL Global X Funds 0 103.93
AVTM American Century ETF Trust - Avantis Total Equity Markets ETF 0 50.0538
Unlock